Ebina, Hirotaka
BIKEN Foundation · Institute for Open and Transdisciplinary Research Initiatives · Research Institute for Microbial Diseases, The University of Osaka · The University of Osaka
3 papers on CoChatORCID 0000-0003-0001-7825
Most cited papers
- Verified
Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus
Ebina, H., Misawa, N., Kanemura, Y., & Koyanagi, Y. (2013) · Scientific Reports
CRISPR and Genetic EngineeringHIV Research and Treatment
Cited by 565
- Verified
Versatile live-attenuated SARS-CoV-2 vaccine platform applicable to variants induces protective immunity
Yoshida, A., Okamura, S., Torii, S., Komatsu, S., Miyazato, P., Sasaki, H., Ueno, S., Suzuki, H., Kamitani, W., Ono, C., et al. (2022) · iScience
SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections Studies
Cited by 20
- Verified
Versatile live attenuated SARS-CoV-2 vaccine platform applicable to variants induces protective immunity
Yoshida, A., Okamura, S., Torii, S., Komatsu, S., Miyazato, P., Ueno, S., Suzuki, H., Kamitani, W., Ono, C., Matsuura, Y., et al. (2021) · iScience
SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections Studies
Cited by 20
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free